Revolutions Medical announces details on MRI paper presentation at IPCV

NewsGuard 100/100 Score

Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCBB:RMCP) announces additional details regarding clinical studies and presentation of related MRI paper at IPCV (Image Processing and Computer Vision) by H. Keith Brown, PhD.

Using Revolutions Medical's proprietary MRI software tools these studies will use existing image data from several regional facilities including the Biological Imaging Research Center at the University of Georgia in Athens. Other clinical MRI imaging facilities are being solicited for participation. They will be based on a recent presentation at IPCV in Las Vegas July 2010 (http://www.world-academy-of-Science.org/worldcomp10/ws/conferences/ipcv10) by Dr. Brown and his colleagues. That presentation entitled Brain MRI Image Segmentation using Fuzzy C-Means Clustering is built on an extensive body of work incorporated into the RevColor MRI tool. The clinical studies will explore the applicability of the Revolutions Medical MRI software tools to image diagnostics, with the goal of eventually improving patient outcomes and cost.

H. Keith Brown, Professor of Anatomy, Philadelphia College of Osteopathic Medicine states, "I am looking forward to exploring these key applications using the Revolutions Medical's MRI software tools. These studies are based on many years of research in this area. I look forward to realizing the promise of this powerful technology in the months to come."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings